In contrast, a centrally active ACE inhibitor, perindopril, was reported to prevent cognitive impairment in chronic central hypoperfusion rats [26] and Alzheimer disease model mice [27]. This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.